Exemestane FDA Approved Drugs
AFINITOR [EverolimusC53H83NO14]
RX
- 10mg (oral tablet)
2.5mg (oral tablet)
7.5mg (oral tablet)
NovartisMar 30, 2009
- Treatment of advanced hormone receptor positive, her2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole.
- Treatment of patients with progessive neuroendocrine tumors of pancreatic origin (pnet) that are unresectable, locally advanced or metastatic.
- Treatment of patients with tuberous sclerosis complex (tsc) who have subependymal giant cell astrocytoma (sega) that requires therapeutic intervention but cannot be curatively resected..
- Treatment of solid excretory system tumors; advanced renal cell carcinoma (rcc), after failure of treatment with sunitinib or sorafenib.
EXEMESTANE [ExemestaneC20H24O2]
RX
- 25mg (oral tablet)
Alvogen MaltaJul 28, 2014
Mylan Pharms IncMar 10, 2017
West-ward Pharms IntApr 1, 2011
Mylan Pharms IncMar 10, 2017
West-ward Pharms IntApr 1, 2011
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.